EDIT Q3 2020 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$63M+1533.1% YoY

Gross Profit

$29M46.0% margin

Operating Income

$9M14.3% margin

Net Income

$8M12.4% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+484.6%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$57M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$597M

Total Liabilities

$156M

Stockholders' Equity

$441M

Cash & Equivalents

$280M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$4M	+1533.1%
Gross Profit	$29M	-$19M	+253.4%
Operating Income	$9M	-$35M	+126.0%
Net Income	$8M	-$33M	+123.7%